Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Masafumi, Izui"'
Autor:
James B Thissen, Mariko Isshiki, Crystal Jaing, Yoshiro Nagao, Dayanara Lebron Aldea, Jonathan E Allen, Masafumi Izui, Thomas R Slezak, Takafumi Ishida, Tetsuya Sano
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209683 (2018)
Kawasaki disease (KD), first identified in 1967, is a pediatric vasculitis of unknown etiology that has an increasing incidence in Japan and many other countries. KD can cause coronary artery aneurysms. Its epidemiological characteristics, such as se
Externí odkaz:
https://doaj.org/article/44ebb7dd5a194fd5b31e44759a5e397f
Autor:
Masafumi Izui, Daisuke Harada, Kaoru Ueyama, Kyoko Oriyama, Yoshihito Ishiura, Hiroko Kashiwagi, Hiroyuki Yamada, Yoshiki Seino
Purpose: The aim of this study was to determine the cardiovascular function and prevalence of valvular diseases in children with osteogenesis imperfecta (OI). Methods: Twenty-eight OI children (mean age: 9.9±6.0 years) underwent echocardiography. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c832d9c8eafcf016831866dd74a9a20e
https://doi.org/10.21203/rs.3.rs-1602896/v1
https://doi.org/10.21203/rs.3.rs-1602896/v1
Autor:
Natsuko Sakamoto, Noriyuki Namba, Kanako Kishimoto, Kaoru Ueyama, Yuki Hanioka, Masafumi Izui, Hiroyuki Tanaka, Yuiko Nagamatsu, Yoshiki Seino, Hiroyuki Yamada, Hiroko Kashiwagi, Kyoko Oriyama, Daisuke Harada, Kawai Kondo
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 33:1391-1397
Objectives Osteogenesis imperfecta (OI) is a skeletal dysplasia characterized by recurrent fractures due to congenital bone fragility. The only bisphosphonate approved for OI in Japan is pamidronate (PAM). To investigate whether monthly intravenous a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86e88552f9593f37727e2b8526a53b8
https://doi.org/10.1515/jpem-2020-0071
https://doi.org/10.1515/jpem-2020-0071
Autor:
Tomoya, Tsuchihashi, Nobuyuki, Kakimoto, Naomi, Kitano, Tomohiro, Suenaga, Kazuyuki, Ikeda, Masafumi, Izui, Naho, Kobayashi, Ken, Yoshimura, Yoshikazu, Nakamura, Hiroyuki, Suzuki
Publikováno v:
Pediatrics International. 64
The treatment guidelines for acute Kawasaki disease (KD) have been revised several times. Moreover, the criterion used to define coronary artery abnormalities (CAAs) has changed from the coronary artery's internal diameter to the Z-score. Treatment f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dcbd9642690a8f617bfe38d02fa9a71
https://doi.org/10.1111/ped.15391
https://doi.org/10.1111/ped.15391
Autor:
Miho Yamamuro, Tomoyuki Akiyama, Daisuke Harada, Toshimi Michigami, Noriyuki Namba, Hiroko Kashiwagi, Kanako Kishimoto, Kawai Kondo, Natsuko Sakamoto, Maki Oyachi, Makoto Tamura, Shin Kikuchi, Masafumi Izui, Yoshiki Seino, Yuiko Nagamatsu, Kaoru Ueyama
Publikováno v:
Clinical Pediatric Endocrinology. 27:179-186
Hypophosphatasia (HPP) is a metabolic bone disease characterized by failure of bone calcification and vitamin B6 dependent seizures. It is caused by loss-of-function mutations in the ALPL gene. A newborn girl required respiratory support by nasal-dir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e03fed15ced34272db1d2fb4b1dae945
https://doi.org/10.1297/cpe.27.179
https://doi.org/10.1297/cpe.27.179
Autor:
Yoshiki Seino, Kyoko Oriyama, Hiroko Kashiwagi, Natsuko Sakamoto, Yuiko Nagamatsu, Noriyuki Namba, Hiroyuki Yamada, Yuki Hanioka, Masafumi Izui Kawai Kondo, Kaoru Ueyama, Daisuke Harada
Publikováno v:
Bone Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87ce2fb9a946b93cbc4db0373674b315
https://doi.org/10.1530/boneabs.7.p153
https://doi.org/10.1530/boneabs.7.p153
Autor:
Thomas R. Slezak, Mariko Isshiki, Tetsuya Sano, Dayanara Lebron Aldea, Yoshiro Nagao, Masafumi Izui, James B. Thissen, Jonathan E. Allen, Crystal Jaing, Takafumi Ishida
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 12, p e0209683 (2018)
PLoS ONE, Vol 13, Iss 12, p e0209683 (2018)
Kawasaki disease (KD), first identified in 1967, is a pediatric vasculitis of unknown etiology that has an increasing incidence in Japan and many other countries. KD can cause coronary artery aneurysms. Its epidemiological characteristics, such as se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746ad51b9cc97858b28f978e4474d3e2
http://europepmc.org/articles/PMC6310298
http://europepmc.org/articles/PMC6310298
Autor:
Hiroko Kashiwagi, Yuki Hanioka, Yukako Nakano, Yoshihito Ishiura, Yuiko Nagamatsu, Yoshiki Seino, Ayako Ogitani, Natsuko Sakamoto, Daisuke Harada, Masafumi Izui, Noriyuki Namba, Kaoru Ueyama, Miho Yamamuro
Publikováno v:
European Journal of Pediatrics
The objective of this study was to evaluate the gain in final height of achondroplasia (ACH) patients with long-term growth hormone (GH) treatment. We analyzed medical data of 22 adult patients (8 males and 14 females) treated with GH at a dose of 0.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f261bcfdc38687bc66f1df1e5a19447
https://pubmed.ncbi.nlm.nih.gov/28501952
https://pubmed.ncbi.nlm.nih.gov/28501952
Autor:
Maki Oyachi, Daisuke Harada, Natsuko Sakamoto, Kaoru Ueyama, Kawai Kondo, Kanako Kishimoto, Masafumi Izui, Yuiko Nagamatsu, Hiroko Kashiwagi, Miho Yamamuro, Makoto Tamura, Shin Kikuchi, Tomoyuki Akiyama, Toshimi Michigami, Yoshiki Seino, Noriyuki Namba
Publikováno v:
Clinical Pediatric Endocrinology; Jul2018, Vol. 27 Issue 3, p179-186, 8p, 2 Diagrams, 3 Charts, 2 Graphs